Glaucoma

Følg
Researchers at the University of Missouri in a lab studying agmatine and thiamine as biomarkers for early glaucoma detection, with vials and eye scans visible.
Billede genereret af AI

Mizzou researchers identify molecules for early glaucoma detection

Rapporteret af AI Billede genereret af AI Faktatjekket

Scientists at the University of Missouri report that two natural molecules — agmatine and thiamine — are reduced in samples from glaucoma patients and could serve as early biomarkers. In preclinical work, the compounds also showed signs of protecting retinal cells, suggesting a path to earlier detection and potential neuroprotective therapies.

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis